Compare · 2 funds side by side · dividends reinvested

IVV and LABD

IVViShares×LABDDirexion×

Versus in desk

02 / 04

IWD−0.4%

Search ETFs and stocks

Portfolio

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$17,398IVV · best of the two

Story of the two · IncomeMost incomeLABD · 6.30% · $630 a year on $10k

Story of the two · RiskSmallest drop

IVV and LABD, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Core S&P 500 ETFLow-Cost Core · S&P 5000.03%1.10%+12.0%+12.2%+21.7%+11.7%−8.9%13.7%$883B1.1

Direxion Daily S&P Biotech Bear 3X ETFLeveraged · An index1.08%6.30%−64.6%−71.9%−66.1%−45.3%−78.6%90.9%$70M1.9

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 12, 2026 · returns include dividends · since: IVV 2000 · LABD 2015

Head to Head

Swap sides Versus in desk

Head to Head

5Y

iShares Core S&P 500 ETF · $883B$17,398

IVV

LABD

Direxion Daily S&P Biotech Bear 3X ETF · $70M$488

$10,000 five years ago, dividends reinvested

IVVMeasureLABD

+12.0%

More Ways to See the Pairs

IVV vs LABD: Top 5 Holdings

Today

IVV

26.8%in top 5

LABD

in top 5[…]

IVVStockLABD

7.9%AAPLnot top 5

6.4%NVDAnot top 5

5.9%MSFTnot top 5

4.0%AMZNnot top 5

2.6%GOOGLnot top 5

Cost, Income and Risk

Fees: IVV, LABD

Today

0.03%lowest, IVV

FundExpense ratioFee$10k

IVV0.03%$3

LABD1.08%$108

End-of-day Nov 12, 2026 · fee on $10,000 a year

Yields: IVV, LABD

1Y

6.30%highest, LABD

FundTrailing yieldYield

Popular Pairs Near These Two

SPYM vs SPY

YTD

SPDRSPYM

+12.0%

SPYSPDR

+11.9%

+12.0%Year to date+11.9%

1.0%Yield1.0%

$183BAssets$793B

1–0SPYM wins

End-of-day Nov 12, 2026

VOO vs IVV

YTD

VanguardVOO

+11.9%

IVViShares

+12.0%

+11.9%

SCHD vs VIG

YTD

SchwabSCHD

+34.2%

VIGVanguard

+16.0%

Year to dateJan 1 → Nov 12

−64.6%

+12.2%1 yearTotal return−71.9%

+21.7%3 years · per year$10,000 became $18,019 · $391−66.1%

+11.7%5 years · per year$10,000 became $17,398 · $488−45.3%

0.03%Expense ratio$3 · $108 a year on $10k · lower is better1.08%

1.10%Trailing 12-mo yield$110 · $630 a year on $10k6.30%

−8.9%Worst dropSmaller is better−78.6%

13.7%VolatilityLower is calmer90.9%

IVVLABD Winner of the row, in its colourEach row: the bigger of the two fills its side

7–1IVV wins

End-of-day Nov 12, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

Held in common[…]

End-of-day Nov 12, 2026 · share of each fund

IVV vs LABD Returns, Every Period

5Y

iSharesIVV

+11.7%

5 years, per year

LABDDirexion

−45.3%

5 years, per year

IVVLABDFaded: behind in that period

4–0IVV wins

End-of-day Nov 12, 2026 · dividends in · faded = behind in that period

Core vs Leveraged: IVV vs LABD

YTD

iSharesIVV

+12.0%

LABDDirexion

−64.6%

+12.0%Year to date−64.6%

−8.9%Worst drop · 1Y−78.6%

13.7%Volatility · 1Y90.9%

1.1%Yield6.3%

$883BAssets$70.1M

3–1IVV wins

End-of-day Nov 12, 2026 · smaller drop and lower volatility win

$10k

LABD6.30%$630

IVV1.10%$110

End-of-day Nov 12, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$522most kept, LABD

LABD$630 − $108 = $522

IVV$110 − $3 = $107

KeptFee

End-of-day Nov 12, 2026 · yield in dollars minus the fee

Overlap: IVV, LABD

Today

[…]holdings […]

IVVLABD

IVV—[…]

LABD[…]—

End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+12.2%IVV, at 13.7% volatility

IVVWorst drop−8.9%13.7% vol

LABDWorst drop−78.6%90.9% vol

End-of-day Nov 12, 2026 · up and left is better

Paid More vs Made More

YTD

LABDIVV

−64.6%Year to date+12.0%

6.3%Yield1.1%

−71.9%Past year+12.2%

1.08%Fee0.03%

3–1IVV wins

End-of-day Nov 12, 2026

Year to date

+12.0%

1.1%Yield1.1%

$1.00TAssets$883B

1–0IVV wins

End-of-day Nov 12, 2026

+34.2%Year to date+16.0%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 12, 2026

Loading…

IVV and LABD

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two